At the molecular level, the possible reason for this was these two colorectal cancers cells used in the study had different mutations status in several critical genes involved in colorectal cancer in addition to BRAF (HCT-116 wt; HT-29 V600E) including P53 (HCT-116 wt; HT-29 mutation R273H), K-ras (HCT-116 mutation G13D; HT-29 wt) and PIK3CA (HCT-116 H1047R; HT-29 wt) [40]. Here, TP53 is linked to colorectal cancer.